NCT00679094View on ClinicalTrials.gov

Bowman-Birk Inhibitor Concentrate in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Healthy, no Evidence of Disease
Interventions
DRUG

Bowman-Birk inhibitor concentrate

Given orally

OTHER

placebo

Given orally

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19104

Abramson Cancer Center of The University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00679094 - Bowman-Birk Inhibitor Concentrate in Healthy Men | Biotech Hunter | Biotech Hunter